- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic virotherapy for urological cancers
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 13, Issue 6, Pages 334-352
Publisher
Springer Nature
Online
2016-05-25
DOI
10.1038/nrurol.2016.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results
- (2016) Solvej Lippert et al. Biomarkers in Medicine
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Tuning Surface Charge and PEGylation of Biocompatible Polymers for Efficient Delivery of Nucleic Acid or Adenoviral Vector
- (2015) Joung-Woo Choi et al. BIOCONJUGATE CHEMISTRY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
- (2015) H. Gevensleben et al. CLINICAL CANCER RESEARCH
- The mechanisms of genetically modified vaccinia viruses for the treatment of cancer
- (2015) Artrish Jefferson et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PD-1/PD-L1 inhibitors
- (2015) Joel Sunshine et al. CURRENT OPINION IN PHARMACOLOGY
- Interleukin-12: Functional activities and implications for disease
- (2015) Sebastian Zundler et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
- (2015) Edgardo D. Carosella et al. EUROPEAN UROLOGY
- Arming oncolytic viruses to leverage antitumor immunity
- (2015) Tanja D de Gruijl et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Development of PROSTVAC immunotherapy in prostate cancer
- (2015) Parminder Singh et al. Future Oncology
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy
- (2015) Joung-Woo Choi et al. JOURNAL OF CONTROLLED RELEASE
- pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis
- (2015) Joung-Woo Choi et al. JOURNAL OF CONTROLLED RELEASE
- Replicating poxviruses for human cancer therapy
- (2015) Manbok Kim JOURNAL OF MICROBIOLOGY
- BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress
- (2015) Victoria Roulstone et al. MOLECULAR THERAPY
- In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells
- (2015) Brienne A. McKenzie et al. NEURO-ONCOLOGY
- A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report
- (2015) E . Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Immunologic Checkpoints Blockade in Renal Cell, Prostate, and Urothelial Malignancies
- (2015) Sergio Bracarda et al. SEMINARS IN ONCOLOGY
- Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder
- (2015) Line Hammer Dohn et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
- (2015) Hanni Uusi-Kerttula et al. Viruses-Basel
- Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting
- (2015) Munitta Muthana et al. Nature Communications
- Oncolytic viruses: From bench to bedside with a focus on safety
- (2015) Pascal RA Buijs et al. Human Vaccines & Immunotherapeutics
- Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients
- (2015) Hardev Pandha et al. Journal for ImmunoTherapy of Cancer
- Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
- (2015) Susanne Fuessel et al. BMC CANCER
- Association of oncolytic adenoviruses with chemotherapies: An overview and future directions
- (2014) Christian Bressy et al. BIOCHEMICAL PHARMACOLOGY
- Encapsulation of adenovirus serotype 5 in anionic lecithin liposomes using a bead-based immunoprecipitation technique enhances transfection efficiency
- (2014) Natalie Mendez et al. BIOMATERIALS
- Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer
- (2014) S Gholami et al. CANCER GENE THERAPY
- A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates
- (2014) Caroline Jochems et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition
- (2014) Yifeng Jing et al. CANCER LETTERS
- Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
- (2014) C. Bolyard et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
- (2014) Gui Lee et al. CURRENT CANCER DRUG TARGETS
- Strategies for targeting the androgen receptor axis in prostate cancer
- (2014) Brett S. Carver DRUG DISCOVERY TODAY
- Molecular insights into the development of T cell-based immunotherapy for prostate cancer
- (2014) Baijun Dong et al. Expert Review of Clinical Immunology
- Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer
- (2014) J Kim et al. GENE THERAPY
- Prostate cancer vaccines in combination with additional treatment modalities
- (2014) Matthew A. Uhlman et al. IMMUNOLOGIC RESEARCH
- Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials
- (2014) Sufia Butt Hassan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
- (2014) Mikko Siurala et al. INTERNATIONAL JOURNAL OF CANCER
- Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer
- (2014) Jayakumar S. Poovassery et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Mitogen-Activated Protein Kinase-Interacting Kinase Regulates mTOR/AKT Signaling and Controls the Serine/Arginine-Rich Protein Kinase-Responsive Type 1 Internal Ribosome Entry Site-Mediated Translation and Viral Oncolysis
- (2014) M. C. Brown et al. JOURNAL OF VIROLOGY
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
- (2014) Michael L. Megison et al. PLoS One
- Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
- (2014) Hong Jiang et al. PLoS One
- Enhanced Antitumor Efficacy of an Oncolytic Herpes Simplex Virus Expressing an Endostatin–Angiostatin Fusion Gene in Human Glioblastoma Stem Cell Xenografts
- (2014) Guobin Zhang et al. PLoS One
- Humoral response to a viral glycan correlates with survival on PROSTVAC-VF
- (2014) C. T. Campbell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability
- (2014) Gray Kueberuwa et al. Human Gene Therapy Methods
- Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
- (2014) Jianfang Ning et al. Frontiers in Microbiology
- Trial Watch:
- (2014) Jonathan Pol et al. OncoImmunology
- Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
- (2014) Darren Shafren et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses as Anticancer Vaccines
- (2014) Norman Woller et al. Frontiers in Oncology
- Identification of a New Class of Small Molecules That Efficiently Reactivate Latent Epstein–Barr Virus
- (2013) Nadezhda Tikhmyanova et al. ACS Chemical Biology
- Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
- (2013) A. Castleton et al. BLOOD
- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Serum Antibodies to Blood Group A Predict Survival on PROSTVAC-VF
- (2013) C. T. Campbell et al. CLINICAL CANCER RESEARCH
- The Mutational Landscape of Prostate Cancer
- (2013) Christopher E. Barbieri et al. EUROPEAN UROLOGY
- Oncolytic measles virus strains as novel anticancer agents
- (2013) Pavlos Msaouel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
- (2013) S O Freytag et al. GENE THERAPY
- Therapeutic targeting of chitosan–PEG–folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy
- (2013) Oh-Joon Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Early Outcomes of Thulium Laser Versus Transurethral Resection of the Prostate for Managing Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis of Comparative Studies
- (2013) Kun Tang et al. JOURNAL OF ENDOUROLOGY
- The Oncolytic Activity of Newcastle Disease Virus in Clear Cell Renal Carcinoma Cells in Normoxic and Hypoxic Conditions: The Interplay Between von Hippel-Lindau and Interferon-β Signaling
- (2013) Wei-Choong Ch'ng et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Intralesional immunotherapy for melanoma
- (2013) Peter Hersey et al. JOURNAL OF SURGICAL ONCOLOGY
- Evolution of Novel Biomarkers for Detection of Prostate Cancer
- (2013) Christopher E. Barbieri JOURNAL OF UROLOGY
- Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer
- (2013) Colin P.N. Dinney et al. JOURNAL OF UROLOGY
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
- (2013) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy
- (2013) R. Shobana et al. JOURNAL OF VIROLOGY
- Adenoviral Vectors Coated with PAMAM Dendrimer Conjugates Allow CAR Independent Virus Uptake and Targeting to the EGF Receptor
- (2013) Alexandra Vetter et al. MOLECULAR PHARMACEUTICS
- Targeting and Killing of Metastatic Cells in the Transgenic Adenocarcinoma of Mouse Prostate Model With Vesicular Stomatitis Virus
- (2013) Maryam Moussavi et al. MOLECULAR THERAPY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver
- (2013) Erkko Ylösmäki et al. PLoS One
- Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus
- (2013) Elisa Callegari et al. PLoS One
- Molecular genetics and genomics progress in urothelial bladder cancer
- (2013) George J. Netto SEMINARS IN DIAGNOSTIC PATHOLOGY
- MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells
- (2013) Jhy-Ming Li et al. Virology Journal
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
- (2012) Hiroshi Miyamoto et al. BJU INTERNATIONAL
- Intravesical therapies for bladder cancer - indications and limitations
- (2012) Callum Logan et al. BJU INTERNATIONAL
- Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
- (2012) B J Passer et al. CANCER GENE THERAPY
- Abstract 2405: Identification of PHLPP as a tumour suppressor reveals the role of pathway feedback compensation in PTEN-mutant prostate cancer progression
- (2012) Muhan Chen et al. CANCER RESEARCH
- Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
- (2012) M. Muthana et al. CANCER RESEARCH
- Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma
- (2012) A. Haseley et al. CANCER RESEARCH
- Viruses in cancer treatment
- (2012) R. Alemany Clinical & Translational Oncology
- Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
- (2012) S. J. Advani et al. CLINICAL CANCER RESEARCH
- Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
- (2012) P. Msaouel et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
- (2012) Sonia Tusell Wennier et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?
- (2012) Keith A. Lawson et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment
- (2012) T Sugiyama et al. GENE THERAPY
- Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer
- (2012) Z Zhai et al. GENE THERAPY
- Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model
- (2012) Zebin Hu et al. HUMAN GENE THERAPY
- Extracellular matrix constituents interfere with Newcastle disease virus spread in solid tissue and diminish its potential oncolytic activity
- (2012) B. Yaacov et al. JOURNAL OF GENERAL VIROLOGY
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors
- (2012) Ryuichi Kanai et al. JOURNAL OF VIROLOGY
- MicroRNA Regulation of Oncolytic Adenovirus 6 for Selective Treatment of Castration-Resistant Prostate Cancer
- (2012) Z. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
- (2012) Otto Hemminki et al. MOLECULAR THERAPY
- Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
- (2012) Evanthia Galanis et al. MOLECULAR THERAPY
- Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer
- (2012) Nicola K Green et al. Nanomedicine
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasmodium falciparum-Infected Erythrocytes Induce Granzyme B by NK Cells through Expression of Host-Hsp70
- (2012) Evelyn Böttger et al. PLoS One
- Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene
- (2012) Miao Ding et al. PLoS One
- Structure of human adenovirus
- (2012) Glen R Nemerow et al. Current Opinion in Virology
- Clinical trials involving the oncolytic virus, reovirus: ready for prime time?
- (2012) Allison J Black et al. Expert Review of Clinical Pharmacology
- Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin
- (2011) Pyung-Hwan Kim et al. BIOMATERIALS
- Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
- (2011) Lucy Heinemann et al. BMC CANCER
- A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy
- (2011) L Chai et al. CANCER GENE THERAPY
- Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma
- (2011) Wei Chen et al. CANCER LETTERS
- Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
- (2011) M. Muthana et al. CANCER RESEARCH
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features
- (2011) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
- (2011) G Cherubini et al. GENE THERAPY
- Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
- (2011) S J Advani et al. GENE THERAPY
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
- (2011) I-K Choi et al. GENE THERAPY
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
- (2011) Camilo Ayala-Breton et al. HUMAN GENE THERAPY
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model
- (2011) Miriam Bazan-Peregrino et al. JOURNAL OF CONTROLLED RELEASE
- Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy
- (2011) Timothy Kottke et al. MOLECULAR THERAPY
- Oncolytic Virus-initiated Protective Immunity Against Prostate Cancer
- (2011) Shashi A Gujar et al. MOLECULAR THERAPY
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
- (2011) Mathias F Leber et al. MOLECULAR THERAPY
- MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity Without Impairing Its Antitumor Efficacy
- (2011) Mina Hikichi et al. MOLECULAR THERAPY
- The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
- (2011) Kelley A Parato et al. MOLECULAR THERAPY
- Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
- (2011) George J. Netto Nature Reviews Urology
- Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing
- (2011) Daniel Abate-Daga et al. PLoS One
- Oncolytic viruses in radiation oncology
- (2011) Yann Touchefeu et al. RADIOTHERAPY AND ONCOLOGY
- Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
- (2011) Ryan S. Noyce et al. PLoS Pathogens
- Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
- (2010) Fabian Benencia et al. CANCER BIOLOGY & THERAPY
- Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis
- (2010) Jun-Nian Zheng et al. CANCER BIOLOGY & THERAPY
- Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues
- (2010) Songqing Fan et al. CANCER BIOLOGY & THERAPY
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Oncolytic adenovirus based on serotype 3
- (2010) O Hemminki et al. CANCER GENE THERAPY
- Oncolysis of Prostate Cancers Induced by Vesicular Stomatitis Virus in PTEN Knockout Mice
- (2010) M. Moussavi et al. CANCER RESEARCH
- Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic
- (2010) C. M. Thirukkumaran et al. CANCER RESEARCH
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer
- (2010) C. Comins et al. CLINICAL CANCER RESEARCH
- Virus therapy for bladder cancer
- (2010) James Burke CYTOKINE & GROWTH FACTOR REVIEWS
- Impact of tumor microenvironment on oncolytic viral therapy
- (2010) Jeffrey Wojton et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
- (2010) Cleo YF Lee et al. MOLECULAR THERAPY
- Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
- (2010) Stephen H Thorne et al. MOLECULAR THERAPY
- A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers
- (2010) Jean-Simon Diallo et al. MOLECULAR THERAPY
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- HPMA copolymers for masking and retargeting of therapeutic viruses☆
- (2009) Kerry D. Fisher et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma
- (2009) Kah-Whye Peng et al. AMERICAN JOURNAL OF HEMATOLOGY
- Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL
- (2009) J A Jiménez et al. CANCER GENE THERAPY
- Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin
- (2009) L Yang et al. CANCER GENE THERAPY
- Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells
- (2009) K-x Zhang et al. CANCER GENE THERAPY
- Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
- (2009) Yuqi Jing et al. CANCER RESEARCH
- Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses
- (2009) R. Strauss et al. CANCER RESEARCH
- MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
- (2009) C. Y. F. Lee et al. CLINICAL CANCER RESEARCH
- Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
- (2009) Kathleen Ebelt et al. EUROPEAN JOURNAL OF CANCER
- Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
- (2009) Ravi A Madan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer
- (2009) M Bauzon et al. GENE THERAPY
- Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
- (2009) E J Ilett et al. GENE THERAPY
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
- (2009) Robin J. Prestwich et al. HUMAN GENE THERAPY
- Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
- (2009) Konstantin Doronin et al. HUMAN GENE THERAPY
- Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 gene
- (2009) Jun Kai Fan et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic virus therapy for prostate cancer
- (2009) Hiroshi Fukuhara et al. INTERNATIONAL JOURNAL OF UROLOGY
- Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion
- (2009) Fraser Conrad et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
- (2009) Shizuko Sei et al. Molecular Cancer
- Targeting Cancer-initiating Cells With Oncolytic Viruses
- (2009) Timothy P Cripe et al. MOLECULAR THERAPY
- Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
- (2009) Candice Willmon et al. MOLECULAR THERAPY
- Intelligent Design: Combination Therapy With Oncolytic Viruses
- (2009) Kathryn Ottolino-Perry et al. MOLECULAR THERAPY
- Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
- (2009) Xifeng Wu et al. NATURE GENETICS
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
- (2009) Jennifer C King et al. NATURE GENETICS
- Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy
- (2009) A. Frentzen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage Depletion Combined with Anticoagulant Therapy Increases Therapeutic Window of Systemic Treatment with Oncolytic Adenovirus
- (2008) E. V. Shashkova et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
- (2008) L. Vidal et al. CLINICAL CANCER RESEARCH
- Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer
- (2008) S.-F. Lin et al. CLINICAL CANCER RESEARCH
- A strategy for systemic delivery of the oncolytic herpes virus HSV1716: redirected tropism by antibody-binding sites incorporated on the virion surface as a glycoprotein D fusion protein
- (2008) J Conner et al. GENE THERAPY
- Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies
- (2008) H Kinoh et al. GENE THERAPY
- Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy
- (2008) A T Power et al. GENE THERAPY
- A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
- (2008) J-L Li et al. GENE THERAPY
- Use of oncolytic viruses for the eradication of drug-resistant cancer cells
- (2008) D. Wodarz Journal of the Royal Society Interface
- Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity
- (2008) Cory Allen et al. MOLECULAR THERAPY
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
- Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus
- (2008) Manish K Aghi et al. MOLECULAR THERAPY
- MicroRNAs fine-tune oncolytic viruses
- (2008) John C Bell et al. NATURE BIOTECHNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- A causal role for ERG in neoplastic transformation of prostate epithelium
- (2008) O. Klezovitch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
- (2008) Adam M. Sonabend et al. STEM CELLS
- History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
- (2007) Harry W. Herr et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More